Effect of daily tadalafil on reported outcomes in patients with erectile dysfunction and depressive symptoms: STROBE, a case–control study

Erectile dysfunction (ED) and depression are closely related. We sought to determine ED and depression were improved by tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor, at 5 mg daily, in this case–control study. Participants were men aged 20 to 65 years with ED for >3 months, International...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyu Shik, Jeong, Tae Yoong, Moon, Hong Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306377/
https://www.ncbi.nlm.nih.gov/pubmed/32502017
http://dx.doi.org/10.1097/MD.0000000000020546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306377/
https://www.ncbi.nlm.nih.gov/pubmed/32502017
http://dx.doi.org/10.1097/MD.0000000000020546

Ejemplares similares